COVID-19

Even after controlling for differences in age and BMI, investigators observe a greater burden of sleep health on those who had severe COVID-19 versus the general population.

Dr. Aric Prather and his team at UCSF are running a large study that began in March 2021 which follows healthy individuals through the COVID-19 vaccination and booster process.

Sleep expert Aric Prather, PhD, presented a discussion at SLEEP 2022 that focused on how the immune system and sleep are related to the "ongoing and protracted" impact of the COVID-19 pandemic.

Primary care provider Dr. Gerald Smetana shares key information and resources to give PCPs all they need know about prescribing outpatient therapies for COVID-19.

COVID-19 has raised additional concerns for rheumatologists, especially regarding health care for patients with rheumatic diseases.

APA president-elect Rebecca W. Brendel, MD, JD, discusses the need to prepare for a "twin mental health pandemic" while continuing to appropriately facilitate innovations in psychiatric care.

New data suggest pediatric patients with a history of cardiac arrest are highly susceptible to hospitalization if infected with SARS-CoV-2.

Investigators in a new multicenter study observed poor vaccine-induced serological responses in patients treated with infliximab or tofacitinib.

New data suggest prediction of SARS-CoV-2 and bacterial co-infection or superinfection could be provided for hospitalized patients.

Dr. Gerald Smetana encourages PCPs to familiarize themselves with the outpatient drug options for managing COVID-19 because of the limited treatment window for administration.

Dr. Tara Vijayan talks about how primary care physicians can be best combat misinformation.

High-risk individuals should be targeted when drug scarcity comes into play.

There remains a need to develop more antivirals that can be easily scaled up for COVID-19.

These findings suggest the importance of COVID-19 vaccination for patients with OHT.

There is concern for cardiovascular patients over missed screenings during the pandemic.

investigators initially theorized the drug may positively impact patients with COVID-19 treated with ruxolitinib.

Females were disproportionately affected by some of the restrictions put in place in the early stages of the COVID-19 pandemic.

The company reported interim results at a meeting this week showing multiple formulations were tolerable and safe. Next comes a phase 2 trial.

Bianca K. Frogner, PhD, discusses the prevalence of burnout and job dissatisfaction observed across various health care worker roles and settings.

Investigators noted selection bias and unaccounted-for confounders may make the increase in RVO incidence coincidental to COVID-19 infection.

“Understanding the drivers of this increased risk in women with gout warrants further investigation in larger datasets," investigators stated.

The adverse event rate was 2.2% for patients with IBD following 1 dose of the vaccine.

At the outset of the COVID-19 pandemic, there were concerns that patients with rheumatoid arthritis would be more vulnerable due to their condition and its treatment. What impact has the availability of vaccines against COVID-19 had on the vulnerability of patients with rheumatoid arthritis? Test your knowledge with this quiz.

A survey analysis suggests the worst of turnover in the workforce occurred in 2020, but focus is needed to recover health care workers from specific fields.

“These data suggest that vaccine responses are reduced but can be improved by sufficient vaccine/virus exposure,” investigators stated.

National registry data suggest management and outcomes of ST-elevation myocardial infarction are returning to pre-pandemic levels, though vaccinated patients have fared better in mortality.

Furthermore, psoriatic treatment did not appear to significantly reduce COVID-19 vaccine efficacy.

Investigators conducted the largest study on SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses.

Patients with rheumatic disease were more likely to have a Pulmonary X-Ray Severity score >9, were more likely to require mechanical ventilation, and had a higher risk of death when compared with controls.

The relative risk of hospitalization was substantially lower for patients with IBD and COVID-19 who were treated with biologics (compared to patients not treated with biologics.